Following development by a clinical working group and review by CRG, we now seek comments on the draft update of the GMMMG High Cost Drugs Inflammatory Bowel Disease Pathway.
The consultation will run for 6 weeks, closing at 5pm on 30th August. To take part, please visit the consultations page.